2. The discovery of the Pseudomonas-associated phage anti-CRISPR system opens a discussion of whether other bacteria-associated phages have developed similar strategies. The authors declare that the ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...

24, 2025 (GLOBE NEWSWIRE) -- SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24 ...

This system and its uses ... and eukaryotes using CRISPR-Cas. SNIPR's patent filings were the first in the field to demonstrate the selective killing of bacteria in a mixed species population ...

NanoCas is the first ultracompact CRISPR system capable of efficient extrahepatic editing when delivered systemically using a single AAV vector. This work is published on bioRxiv in a preprint ...

suggesting that phages have evolved counter strategies to thrive within bacteria despite these mechanisms 2. Thus, both bacterial CRISPR system and phage anti-CRISPR system are part of a ...

24, 2025 (GLOBE NEWSWIRE) -- SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24 ...

Figure 1 Schematic of the CRISPR-Cas system of the natural prokaryotic immune system. After viral invasion, certain bacteria can incorporate a viral gene fragment into their CRISPR storage space. When ...

To this end, we propose and solve a simple phenomenological model of CRISPR-based adaptive immunity in microbes ... equations that are used to derive mean-field equations for this dynamical system ...